Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726785 | PMC |
| http://dx.doi.org/10.1016/j.jdcr.2024.11.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bruising, hives, and joint pain in a 3-year-old boy.
JAAD Case Rep
January 2025
Department of Dermatology, Medical College of Georgia at Augusta University, Augusta, Georgia.
Multisystem Involvement in a Pediatric Patient With Hypermobile Ehlers-Danlos Syndrome: A Case Report of the Diagnostic Complexity and Management Challenges.
Cureus
June 2024
Department of Pediatrics, Ascension St. Vincent's, Jacksonville, USA.
Ehlers-Danlos syndrome (EDS) is a collection of genetic disorders caused by abnormalities in collagen and typified by hyperflexible joints, hyperextensible skin, and a tendency for easy bruising and tissue injuries. Hypermobile Ehlers-Danlos syndrome (hEDS), the most common subtype, presents a diagnostic challenge due to the lack of specific genetic markers. This case report describes a 13-year-old girl with hEDS, presenting with hypermobility, thoracolumbar scoliosis, constipation, glucosuria, microscopic hematuria, urticaria, and intermittent episodes of bilateral hand and feet swelling.
View Article and Find Full Text PDFTreatment of periorbital veins with vascular laser: A systematic review and retrospective case series.
J Cosmet Dermatol
August 2024
Non surgical aesthetics, Drs Tatiana + Rishi Advanced Aesthetics, Non surgical aesthetics, London, UK.
Introduction: Vascular lasers may represent a promising treatment option for periorbital veins. This article aims to: (1) systematically review the literature on the safety and effectiveness of vascular laser treatment for periorbital veins and (2) assess safety and effectiveness through a retrospective case series.
Methods: Systematic review: Articles that assessed the safety and effectiveness of vascular laser treatment for periorbital veins were included and quality assessed using the Downs and Black checklist.
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey.
Clin Transl Allergy
October 2023
Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Background: Urticarial vasculitis (UV) should be differentiated from chronic spontaneous urticaria (CSU) in patients initially presenting with recurrent wheals, although criteria for differential diagnosis remain ill-defined.
Objectives: To set the goals, define criteria and unmet needs in UV diagnosis and differential diagnosis with CSU, and explore the possibility of coexistence of both diseases.
Methods: Thirteen experts experienced in UV research participated in a Delphi survey of European Academy of Allergy and Clinical Immunology taskforce.
PRO-CTCAE reveals under-recognition of dermatologic symptom burden in hospitalized cancer patients.
Support Care Cancer
May 2023
Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 545 East 73rd Street, New York, NY, 10021, USA.
Purpose: Dermatologic adverse events (dAEs) occur frequently in hospitalized patients and can significantly reduce quality of life. Physicians grade dAEs using the Common Terminology Criteria of Adverse Events (CTCAE). However, they often underestimate symptom frequency and severity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!